Skip to main content

Danahy Kevin Patrick's Form 4 filing

Pulse Biosciences, Inc. (PLSE) · filed Feb 17, 2026

Accession no.
0001437749-26-004438
Filed
Feb 17, 2026
Trade date
Feb 12-17, 2026
Filing delay
5 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.41M. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Danahy Kevin PatrickCIK 0001913245Officer (Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 12, 2026Common StockMOption exerciseAcquired+20,000$1.53+$30,60063,298Direct
Feb 12, 2026Common StockSSaleDisposed−20,000$23.37−$467,40043,298Direct
Feb 13, 2026Common StockMOption exerciseAcquired+20,000$1.53+$30,60063,298Direct
Feb 13, 2026Common StockSSaleDisposed−20,000$23.53−$470,60043,298Direct
Feb 17, 2026Common StockMOption exerciseAcquired+20,000$1.53+$30,60063,298Direct
Feb 17, 2026Common StockSSaleDisposed−20,000$23.63−$472,60043,298Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 12, 2026Common StockMOption exerciseDisposed−20,000$0.00$0345,000Direct
Feb 13, 2026Common StockMOption exerciseDisposed−20,000$0.00$0325,000Direct
Feb 17, 2026Common StockMOption exerciseDisposed−20,000$0.00$0305,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)